LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 96 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2017. The put-call ratio across all filers is 1.92 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $330,000 | -90.3% | 35,023 | -79.3% | 0.02% | -87.2% |
| Q3 2018 | $3,404,000 | -39.9% | 169,085 | -13.0% | 0.19% | -41.4% |
| Q2 2018 | $5,666,000 | -11.5% | 194,240 | -9.6% | 0.32% | -9.6% |
| Q1 2018 | $6,400,000 | -27.3% | 214,917 | -21.5% | 0.36% | -15.5% |
| Q4 2017 | $8,808,000 | -39.8% | 273,700 | -35.0% | 0.42% | -29.4% |
| Q3 2017 | $14,642,000 | – | 420,984 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
| TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
| FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
| WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
| PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
| Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |